Export financials
Reading International (RDI)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.

Reading International Financial Ratios 2025-2008 | RDI
Brief overview of Reading International's multiples and efficiency
This overview follows the five latest available observations from 2015 through 2021.
The current valuation set is P/E 3.03x (median 12.23x), EV/EBITDA 59.32x (median 59.32x), P/S 0.13x (median 0.18x). Valuation is roughly 31.3% below five-year reference levels. The discount may reflect opportunity or higher perceived risk.
Current earnings relative to valuation equal about 33.1% on the 1/P/E measure. This is a valuation reference, not an expected payout.
Current measures of operating quality are ROE 77.5%, ROA -3.3%, ROCE 29.1%. Current return ratios are negative, materially weakening the fundamental profile.
Current PEG is 0.28x; the market pays comparatively little per unit of expected growth.
The cash cycle changed only slightly and ended at 8.8 days.
What the ratios show
Reading International's discount may reflect genuine profitability issues rather than market inefficiency alone.
Annual Financial Ratios Reading International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.8 | -0.9 | -1.3 | -2.0 | 3.0 | -2.4 | -7.1 | 25.2 | 12.2 | 39.6 | 11.1 | 11.0 | 19.3 | 9882.2 | 9.7 | -7.3 | 14.8 | - | |
P/S |
0.1 | 0.1 | 0.2 | 0.3 | 0.7 | 2.0 | 0.7 | 1.2 | 1.4 | 1.4 | 1.0 | 1.1 | 0.7 | 438.1 | 0.4 | 0.4 | 0.4 | - |
EPS |
-0.6 | -1.6 | -1.4 | -1.6 | 1.5 | -3 | -1.2 | 0.6 | 1.3 | 0.4 | 1.0 | 1.1 | 0.4 | -0.0 | 0.4 | -0.6 | 0.3 | - |
EV (Enterprise Value) |
468 M | 495 M | 528 M | 565 M | 596 M | 741 M | 712 M | 608 M | 607 M | 613 M | 471 M | 502 M | 402 M | 108 B | 370 M | 371 M | 65.7 M | -30.9 M |
EBITDA per Share |
0.35 | 0.08 | 0.29 | -0.34 | -0.87 | -1.79 | 1.41 | 2.02 | 1.63 | 1.54 | 1.62 | 1.61 | 1.55 | 0.000809 | 1.57 | 1.26 | 1.29 | - |
EV/EBITDA |
59.3 | 283.3 | 82.6 | -74.6 | -30.8 | -8.7 | 13.4 | 11.0 | 13.2 | 13.8 | 9.7 | 10.5 | 8.5 | 5848.7 | 7.7 | 13.0 | 2.3 | - |
PEG |
0.28 | 0.01 | 0.01 | 0.03 | -0.05 | 0.05 | 7.71 | -0.47 | 0.05 | -0.67 | -1.02 | 0.06 | 0.02 | -98.93 | 0.05 | - | - | - |
P/B |
-1.4 | -6.5 | 1.2 | 1.1 | 0.9 | 2.0 | 1.4 | 2.1 | 2.1 | 2.6 | 1.9 | 2.2 | 1.5 | 870.1 | 0.8 | 0.8 | - | - |
P/CF |
-16.2 | -8.1 | -4.2 | -2.7 | -7.2 | -5.3 | 7.7 | -11.7 | -8.3 | -19.6 | -10.3 | 21.1 | 34.2 | 50.6 | 5.1 | 4.0 | 5.0 | - |
ROE % |
77.53 | 808.91 | -92.70 | -57.57 | 30.38 | -80.32 | -18.93 | 8.15 | 17.52 | 6.61 | 17.14 | 20.13 | 7.72 | 8.80 | 8.05 | -11.32 | 5.53 | - |
ROA % |
-3.25 | -7.49 | -5.75 | -6.16 | 4.64 | -9.45 | -3.92 | 3.27 | 7.33 | 2.32 | 6.07 | 6.40 | 2.34 | 2.53 | 2.31 | -2.94 | - | - |
ROCE % |
29.10 | 321.56 | -36.36 | -45.31 | -39.78 | -75.53 | 6.53 | 6.81 | 6.00 | 5.98 | 7.73 | 7.18 | 8.06 | 5.22 | 5.32 | 11.69 | 12.63 | - |
Current Ratio |
1.0 | 1.0 | 1.1 | 1.1 | 1.2 | 1.1 | 1.3 | 0.4 | 0.4 | 1.1 | 0.5 | 0.9 | 0.4 | 0.7 | 0.7 | 1.4 | - | - |
DSO |
8.8 | 11.1 | 11.3 | 10.4 | 10.2 | 22.3 | 10.0 | 12.7 | 19.2 | 13.8 | 17.3 | 16.3 | 12.8 | - | 10.4 | 4.4 | - | - |
DIO |
- | - | - | - | - | - | - | 2.2 | 2.4 | 2.4 | 2.0 | 1.9 | 1.7 | - | 2.0 | - | - | - |
DPO |
- | - | - | - | - | - | - | 53.9 | 80.6 | 65.1 | 59.8 | 50.5 | 44.8 | - | 43.7 | - | - | - |
Operating Cycle |
8.8 | 11.1 | 11.3 | 10.4 | 10.2 | 22.3 | 10.0 | 14.9 | 21.6 | 16.3 | 19.3 | 18.1 | 14.5 | - | 12.3 | 4.3 | - | - |
Cash Conversion Cycle |
8.8 | 11.1 | 11.3 | 10.4 | 10.2 | 22.3 | 10.0 | -39.0 | -58.9 | -48.8 | -40.5 | -32.4 | -30.3 | - | -31.4 | 4.3 | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Financial Ratios Reading International
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.36 | -0.18 | -0.12 | -0.21 | -0.31 | -0.57 | -0.59 | -0.2 | -0.12 | -0.5 | - | -0.23 | -0.11 | -0.7 | - | -0.46 | 1.04 | 0.87 | -0.8 | -0.88 | -1.04 | -0.27 | -0.99 | 0.04 | 0.1 | -0.09 | 0.21 | 0.06 | 0.22 | 0.13 | 0.33 | 0.07 | 0.82 | 0.13 | 0.01 | 0.17 | 0.13 | 0.09 | 0.14 | 0.02 | 0.69 | 0.14 | 0.74 | 0.17 | 0.2 | -0.01 | 0.14 | 0.1 | 0.18 | -0.03 | -0.06 | 0.02 | 0.01 | -0.01 | -0.21 | - | 0.76 | -0.11 |
EBITDA per Share |
-0.02 | 0.13 | 0.28 | -0.16 | 0.16 | -0.16 | -0.15 | 0.25 | 0.29 | -0.15 | - | -0.08 | 0.17 | -0.28 | - | -0.25 | -0.31 | -0.38 | - | -0.54 | -0.78 | -0.08 | - | 0.38 | 0.49 | 0.18 | - | 0.45 | 0.62 | 0.48 | - | 0.34 | 0.51 | 0.41 | - | 0.46 | 0.42 | 0.36 | - | 0.28 | 0.6 | 0.39 | - | 0.43 | 0.53 | 0.27 | - | 0.4 | 0.49 | 0.28 | - | 0.35 | 0.42 | 0.39 | - | 0.49 | 0.51 | 0.27 |
ROE % |
160.00 | -554.89 | -800.46 | -909.79 | -979.18 | -302.03 | -112.72 | -45.65 | -38.15 | -48.84 | -27.04 | -36.79 | -9.96 | 16.05 | 32.58 | 11.15 | -3.83 | -52.30 | -82.90 | -81.78 | -56.43 | -25.51 | -19.53 | 3.56 | 3.62 | 4.69 | 7.97 | 9.38 | 9.58 | 17.56 | 17.57 | 13.63 | 15.45 | 6.77 | 6.61 | 9.05 | 6.63 | 16.58 | 17.36 | 28.16 | 30.96 | 22.64 | 20.13 | 9.36 | 8.32 | 8.12 | 7.72 | 4.00 | 2.24 | -1.10 | -0.72 | -3.78 | -4.04 | 9.86 | 8.05 | 0.03 | 14.09 | -2.00 |
ROA % |
-4.53 | -4.06 | -5.69 | -7.76 | -7.18 | -7.75 | -6.04 | -3.36 | -3.75 | -5.55 | -3.57 | -5.02 | -1.06 | 2.63 | 4.94 | 2.42 | 1.08 | -5.29 | -9.45 | -11.00 | -8.09 | -4.45 | -3.92 | 1.27 | 1.42 | 2.20 | 3.20 | 3.84 | 3.93 | 7.32 | 7.35 | 5.68 | 6.26 | 2.49 | 2.32 | 3.20 | 2.35 | 5.91 | 6.19 | 9.51 | 10.39 | 7.29 | 6.40 | 2.93 | 2.57 | 2.46 | 2.34 | 1.22 | 0.68 | -0.33 | -0.21 | -1.08 | -1.16 | 2.83 | 2.31 | 0.01 | 4.05 | -0.58 |
ROCE % |
64.77 | 17.22 | -112.31 | -117.17 | -200.20 | -163.10 | -51.76 | -19.10 | -23.43 | -39.79 | -24.33 | -34.91 | -35.78 | -48.46 | -35.86 | -58.21 | -76.17 | -74.53 | -59.93 | -57.83 | -31.26 | -3.72 | 5.33 | 7.90 | 10.69 | 9.69 | 10.70 | 12.76 | 14.57 | 12.81 | 9.58 | 14.23 | 16.44 | 15.35 | 12.23 | 14.58 | 17.82 | 17.48 | 14.18 | 19.01 | 23.32 | 17.45 | 13.51 | 18.49 | 20.28 | 15.79 | 13.77 | 17.04 | 16.53 | 13.71 | 11.54 | 17.21 | 19.83 | 16.97 | 13.16 | 5.67 | 5.90 | 1.60 |
Current Ratio |
0.9 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | - | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.1 | 1.1 | 1.1 | 1.1 | 1.3 | 1.3 | 1.3 | 1.3 | 1.7 | 1.7 | 1.7 | 1.7 | 1.8 | 1.8 | 1.8 | 1.8 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 |
DSO |
7.1 | 5.4 | 3.6 | 7.8 | 9.9 | 14.4 | 7.2 | 3.7 | 7.2 | 11.0 | - | 8.8 | 6.1 | 9.9 | - | 7.7 | 6.7 | 10.6 | 14.8 | 21.8 | 65.0 | 8.8 | 9.4 | 9.2 | 8.5 | 11.2 | 9.8 | 9.9 | 8.7 | 12.7 | 16.6 | 18.0 | 16.4 | 14.3 | 11.9 | 11.2 | 12.0 | 13.2 | 13.7 | 15.8 | 12.6 | 16.1 | 16.8 | 15.9 | 14.8 | 16.1 | 13.1 | 12.7 | 11.9 | 13.5 | 11.9 | 12.2 | 12.3 | 11.3 | 11.1 | 9.6 | 9.5 | - |
Operating Cycle |
- | 5.4 | 3.6 | 7.8 | 9.9 | 14.4 | - | - | 7.2 | 11.0 | - | 8.8 | 6.1 | 9.9 | - | 7.7 | 6.7 | 10.6 | 14.8 | 21.8 | 65.0 | 8.8 | 9.4 | 9.2 | 8.5 | 11.2 | 9.8 | 9.9 | 8.7 | 12.7 | 16.6 | 18.0 | 16.4 | 14.3 | 11.9 | 11.2 | 12.0 | 13.2 | 13.7 | 15.8 | 12.6 | 16.1 | 16.8 | 15.9 | 14.8 | 16.1 | 13.1 | 12.7 | 11.9 | 13.5 | 11.9 | 12.2 | 12.3 | 11.3 | 11.1 | 9.6 | 9.5 | - |
Cash Conversion Cycle |
- | 5.4 | 3.6 | 7.8 | 9.9 | 14.4 | - | - | 7.2 | 11.0 | - | 8.8 | 6.1 | 9.9 | - | 7.7 | 6.7 | 10.6 | 14.8 | 21.8 | 65.0 | 8.8 | 9.4 | 9.2 | 8.5 | 11.2 | 9.8 | 9.9 | 8.7 | 12.7 | 16.6 | 18.0 | 16.4 | 14.3 | 11.9 | 11.2 | 12.0 | 13.2 | 13.7 | 15.8 | 12.6 | 16.1 | 16.8 | 15.9 | 14.8 | 16.1 | 13.1 | 12.7 | 11.9 | 13.5 | 11.9 | 12.2 | 12.3 | 11.3 | 11.1 | 9.6 | 9.5 | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Multiples are an important financial analysis tool for the company Reading International, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.